Wei Wu

Corporate Officer/Principal at Johnson & Johnson Innovation - JJDC, Inc.

Finance

Consumer Services

Health Technology

Profile

Wei Wu is currently a Principal at Johnson & Johnson Innovation - JJDC, Inc. Prior to this, he worked as a Senior Associate at IIF Management Co. LLC from 2019 to 2021.
He also served as a Board Member at Immpact Bio USA, Inc. from 2021 to 2022 and as an Advisory Board Member at Cura Therapeutics from 2019 to 2020.
Mr. Wu received his undergraduate degree from Peking University and his doctorate degree from the University of California.

Wei Wu active positions

Companies	Position	Start
Johnson & Johnson Innovation - JJDC, Inc. Johnson & Johnson Innovation - JJDC, Inc. Investment ManagersFinance Johnson & Johnson Innovation JJDC Inc (Johnson & Johnson Innovation JJDC) is a venture capital subsidiary of Johnson & Johnson founded in 1973. The firm is headquartered in New Brunswick, New Jersey.	Corporate Officer/Principal	2021-01-31

All active positions of Wei Wu

Former positions of Wei Wu

Companies	Position	End
Immpact Bio USA, Inc. Immpact Bio USA, Inc. BiotechnologyHealth Technology ImmPACT Bio USA, Inc. operates as a cell therapy company. The firm develops potent and selective engineered T-cells for the treatment of solid tumors. The company is headquartered in Camarillo, CA.	Director/Board Member	2021-12-31
IIF Management Co. LLC IIF Management Co. LLC Investment ManagersFinance IIF Management Co LLC (Illumina Ventures) is a venture capital firm founded in 2015 by Nicholas J. Naclerio. The firm is headquartered in Foster City, California.	Private Equity Analyst	2020-12-31
Cura Therapeutics Cura Therapeutics Pharmaceuticals: MajorHealth Technology Cura Therapeutics is a Canadian company that is developing innovative immunotherapies to cure cancer and infectious diseases. The company is based in QuÃƒÂ©bec, Canada. The company is developing a first-in-class multifunctional immunotherapy platform that harnesses cytokines and immune receptors to create multifunctional proteins with potent anti-cancer and anti-viral properties. The company's lead immunotherapy, CT101, is a multifunctional cytokine fusion protein that activates and synchronizes several immune system mechanisms to destroy cancer cells. Cura Therapeutics was founded by Collin Horner, Claudia A. Penafuerte Diaz, and Claudia A. Penafuerte Diaz has been the CEO since incorporation.	Consultant / Advisor	2019-12-31

See the detail of Wei Wu's experience

Training of Wei Wu

Peking University	Undergraduate Degree
University of California	Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Wei Wu's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
Johnson & Johnson Innovation - JJDC, Inc. Johnson & Johnson Innovation - JJDC, Inc. Investment ManagersFinance Johnson & Johnson Innovation JJDC Inc (Johnson & Johnson Innovation JJDC) is a venture capital subsidiary of Johnson & Johnson founded in 1973. The firm is headquartered in New Brunswick, New Jersey.	Finance
IIF Management Co. LLC IIF Management Co. LLC Investment ManagersFinance IIF Management Co LLC (Illumina Ventures) is a venture capital firm founded in 2015 by Nicholas J. Naclerio. The firm is headquartered in Foster City, California.	Finance
Immpact Bio USA, Inc. Immpact Bio USA, Inc. BiotechnologyHealth Technology ImmPACT Bio USA, Inc. operates as a cell therapy company. The firm develops potent and selective engineered T-cells for the treatment of solid tumors. The company is headquartered in Camarillo, CA.	Health Technology
Cura Therapeutics Cura Therapeutics Pharmaceuticals: MajorHealth Technology Cura Therapeutics is a Canadian company that is developing innovative immunotherapies to cure cancer and infectious diseases. The company is based in QuÃƒÂ©bec, Canada. The company is developing a first-in-class multifunctional immunotherapy platform that harnesses cytokines and immune receptors to create multifunctional proteins with potent anti-cancer and anti-viral properties. The company's lead immunotherapy, CT101, is a multifunctional cytokine fusion protein that activates and synchronizes several immune system mechanisms to destroy cancer cells. Cura Therapeutics was founded by Collin Horner, Claudia A. Penafuerte Diaz, and Claudia A. Penafuerte Diaz has been the CEO since incorporation.	Health Technology

See company connections